Direxion MSCI Emerging Over Developed Markets ETF
RWED
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- United States of America
- IPO Date
- Jan 16, 2019
- CIK
- 0001424958
- Similar Companies
- Business
- Direxion MSCI Emerging Over Developed Markets ETF (RWED) is an exchange-traded fund managed by Direxion Shares ETF Trust that seeks daily investment results, before fees and expenses, corresponding to 150% of the performance of the MSCI Emerging Markets IMI Index and -50% of the performance of the MSCI EAFE IMI Index, as measured by the MSCI Emerging Markets IMI - EAFE IMI 150/50 Return Spread Index. The fund provides leveraged long exposure to emerging markets equities, including large-, mid-, and small-cap stocks from countries such as China, India, Brazil, and South Africa, paired with short exposure to developed markets ex-North America equities from regions including Europe, Australasia, and the Far East; it is non-diversified and targets sophisticated investors seeking tactical trading opportunities in global equity market divergences. Direxion Shares ETF Trust, the issuer founded in 1997 and headquartered at 1301 Avenue of the Americas, 28th Floor, New York, New York, operates globally with additional offices in Boston and Hong Kong, offering a broad suite of leveraged, inverse, and single-stock ETFs across sectors like technology, healthcare, and commodities. In a significant operational change, RWED was liquidated and delisted, with trading ceasing and closure to new purchases occurring around September 2020 following a board decision based on recommendations from adviser Rafferty Asset Management, LLC, due to low assets under management and in the best interest of remaining shareholders. Direxion has since focused on expansions including the March 2025 launch of four new single-stock leveraged and inverse ETFs tracking Eli Lilly (LLY) and Palo Alto Networks (PANW) in pharmaceuticals and cybersecurity sectors, as well as December 2024 introductions for Berkshire Hathaway and Palantir, reflecting ongoing innovation in high-conviction trading tools amid a portfolio managing approximately $47-48 billion in assets as of late 2024. The firm continues to prioritize short-term tactical products without recent partnerships, acquisitions, or funding rounds specific to this ETF segment noted in public disclosures.